🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Can we provide precision oncology to cancer patients without high-cost sequencing just by using their tumor H&E images🔬? We are excited to present the first framework for sequencing-less transcriptome-based precision oncology.⚡️ biorxiv.org/content/10.110…

Thank you VentureBeat for selecting me as a finalist for the Women in #AI award! I’m honored to be representing Pangea Biomed and highlighting the importance of female leadership in the #tech, #healthcare and #AI spaces. #VBTransform #VentureBeat venturebeat.com/2022/07/08/mee…

A well-deserved congratulations to our CTO Ranit Aharonov for winning VentureBeat's Women in AI award in the #AI Research category! The full list of winners can be found here: venturebeat.com/2022/07/19/tra… #VBTransform #Research

Glad to share our revised preprint on ENLIGHT, a transcriptomics-based computational approach that predicts response to a variety of targeted & immunotherapies in many cancer types w/o training on prior response data. Gal Dinstag Tuvik Beker Ranit Aharonov bit.ly/ENLIGHTbRxv

We are delighted to share that our recent ENLIGHT manuscript is out in MED! cell.com/med/fulltext/S… ENLIGHT is a powerful unsupervised precision oncology tool that can predict response for a wide variety of drugs with minimal data requirements. A 5 minute TL;DR follows

Exciting to see how our work at Pangea Biomed truly affects people!

Groundbreaking science and invaluable investor support intersected at Pangea this week: with two new peer-reviewed publications, we’re announcing new #funding from Danny Tocatly and NFX @Omri_Drory to bring our seed round to $12M. #PrecisionOncology hitconsultant.net/2022/12/15/pan…

(1/2) ENLIGHT-DeepPT successfully predicts true responders in six independent cohorts with an overall odds ratio of 2.19, increasing the baseline response rate by 38.8% among predicted responders on average. biorxiv.org/content/10.110…

אחד העצורים במחאה נגד המהפכה המשפטית בירושלים הוא פרופ' עמית דניאלי, חבר סגל באוניברסיטה העברית ופרופ' למדעי המחשב. במשטרה טוענים שנעצר על תקיפת שוטרים. זה התיעוד: לקול קריאות "איפה הייתם בחווארה?" שוטרי יס"מ מתנפלים על פרופ' דניאלי ומכניסים אותו לניידת תוך שניות בודדות מ"התקיפה"

אדלשטיין מגלה אומץ ונאמנות למדינה. אותו אומץ שהביא אותו לשבת בכלא בסיביר כדי לעלות לישראל. גיבור ישראל. ישר כוח!

Today in the Knesset of Israel, experts are being prevented from entering committees, and experts who participated in protests are being threatened by coalition members. On the verge of a dictatorship. AIPAC PAC American Jewish Committee House Democrats

Showing support for my 🇮🇱friends: 100s of leaders of the Israeli Health , Wellness & Healthtech sectors, categorically oppose any legislation allowing anyone, including government and/or parliament, to take radically unreasonable decisions w/o imperative ☑️ & balance mechanisms.

An immense gap exists between the investment and innovation going into #precisiononcology and the number of patients who are actually benefiting. Read more from my Q&A w/ᴀᴍɪᴛ ᴄʜᴏᴡᴅʜʀʏ via Pulse 2.0 to learn more about how @Pangeabiomed is solving this. bit.ly/3NYmTBV

אנו חברים וחברות ב - 8400 , כמו גם קבוצת רופאות ורופאים שאינם ברשת הבריאות של 8400, מביעים בזאת את תמיכתנו החזקה בפרופ׳ איתן גלון ומתנגדים מכל וכל להשתלחות הנפשעת של גורמים אלה ואחרים

Huge congratulations to @Pangea Biomed board member Dr. @Lillian Siu on being selected as President-Elect of the AMERICAN Association for Cancer Research Board!

Huge congratulations to @Pangea Biomed advisory board member Dr. @Lillian Siu on being selected as President-Elect of the AMERICAN Association for Cancer Research!

#ASCO24 has begun! My colleague @GalDinstag and I will be on-site representing Pangea Biomed and presenting three posters about our ENLIGHT platform on Saturday, June 1st at 9 am in Hall A. DM or email [email protected] to connect. #Biotech #Cancer #Oncology

Proud to share that Pangea Biomed was named one of Fast Company’s Next Big Things in Tech! The list recognizes the impact of our ENLIGHT platform in democratizing #PrecisionOncology.

What if AI could revolutionize both cancer treatment and drug development? Join me at #PMWC2025 to learn how Pangea Biomed's ENLIGHT platform is doing just that. Oncology Applications (Track 3), February 5 at 3:30pm #PrecisionMedicine #Oncology #Biomarkers #AI Precision Medicine World Conference